CClinicalTrials.gg
CompletedNCT01883336Updated Jun 6, 2019

Long Term Follow up of Small Non-inflammatory Pancreatic Cysts

An observational study in Pancreatic Cysts, sponsored by Universitätsklinikum Hamburg-Eppendorf. Completed at 1 site in Germany. Per ClinicalTrials.gov, last updated 2019-06-06.

Sponsored by Universitätsklinikum Hamburg-Eppendorf · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
300
Sex
All
01

Study summary

This study intends to investigate the long term follow-up of small non-inflammatory pancreatic cysts.

Read the detailed description

This study intends to investigate the long term follow-up of small non-inflammatory pancreatic cysts in a multicenter setting.

Inclusion criteria:

Patients with non-inflammatory pancreatic cystic lesions up to 3 cm in diameter referred to the University Hospital Hamburg Eppendorf, Israelitic Hospital Hamburg, Sana Klinikum Lichtenberg, Berlin and Krankenhaus Märkisch-Oderland,Strausberg from 2002 to 2007 identified from EUS database.

Study design:

At least 5 year-long term follow up by inclusion of clinical data, cross sectional imaging if available or actual US findings.

Primary outcome:

To determine the proportion of patients with increase is size and/or changed appearance

Secondary outcomes:

Rate of patients undergo pancreatic surgery (indication, histology of resected specimen). Rate of patients undergo FNA (fluid analysis, cytology).

02

Conditions studied

  • Pancreatic Cysts

Keywords

  • Incidental pancreatic cysts
03

In context

Cysts

118 studies on the registry are indexed under Cysts; 22 are open to participants now.

This study's planned enrollment of 300 is above the median of 151 across 42 observational studies indexed under Cysts.

Browse Cysts studies →

Lead sponsor

Universitätsklinikum Hamburg-Eppendorf is the lead sponsor of 403 studies on the registry; 83 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients with non-inflammatory pancreatic cystic lesions up to 3 cm in diameter referred to the University Hospital Hamburg Eppendorf, Israelitic Hospital Hamburg, Sana Klinikum Lichtenberg, Berlin and Krankenhaus Märkisch-Oderland,Strausberg.

Inclusion criteria

  • Patients with non-inflammatory pancreatic cystic lesions up to 3 cm in diameter

Exclusion criteria

Exclusion Criteria:

  • acute or chronic pancreatitis
  • pancreatic cysts > 3 cm
  • Lesion suspicious for malignancy
05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
300 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Progress of pancreatic cyst

    To determine the proportion of patients with increase is size and/or changed appearance of pancreatic cyst.

    Time frame: 5 years

07

Study locations

1 site
  • University Hospital Hamburg-Eppendorf
    Hamburg, 20246, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 6, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01883336
Lead sponsor
Universitätsklinikum Hamburg-Eppendorf
Responsible party
Prof. Dr. Thomas Rösch (Prof. Dr. Thomas Roesch, Universitätsklinikum Hamburg Eppendorf, Endoscopy department, Universitätsklinikum Hamburg-Eppendorf) — Principal investigator
First posted
Jun 21, 2013
Start date
Jan 2011
Primary completion
Jul 2016
Completion
Nov 2016
Last update
Jun 6, 2019

Study contacts

Thomas Roesch, Prof. Dr.
principal investigator · Universitätsklinikum Hamburg-Eppendorf

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion